Invetx

company

About

Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology to animal health.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biopharma,Biotechnology,Veterinary
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology to animal health.

Invetx is building the world’s premier animal health biotechnology innovation platform for protein-based therapeutics.

Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, Invetx is focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of animal care.

Invetx's network includes experts in both animal and human health, veterinary scientists and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$25.25M
Invetx has raised a total of $25.25M in funding over 2 rounds. Their latest funding was raised on Sep 30, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 30, 2020 Series A $10.25M 1 Detail
Feb 24, 2020 Series A $15M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Invetx is funded by 1 investors. AbCellera are the most recent investors.
Investor Name Lead Investor Funding Round
AbCellera Series A